[HTML][HTML] Hepatocellular carcinoma: old friends and new tricks
E Kim, P Viatour - Experimental & molecular medicine, 2020 - nature.com
Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer and a leading
cause of cancer-related deaths worldwide. Ninety percent of HCC cases arise from cirrhosis …
cause of cancer-related deaths worldwide. Ninety percent of HCC cases arise from cirrhosis …
[HTML][HTML] Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances
Liver cancer is considered one of the deadliest diseases with one of the highest disease
burdens worldwide. Among the different types of liver cancer, hepatocellular carcinoma is …
burdens worldwide. Among the different types of liver cancer, hepatocellular carcinoma is …
[HTML][HTML] PCSK9 and cancer: Rethinking the link
K Mahboobnia, M Pirro, E Marini, F Grignani… - Biomedicine & …, 2021 - Elsevier
Background Cancer is emerging as a major problem globally, as it accounts for the second
cause of death despite medical advances. According to epidemiological and basic studies …
cause of death despite medical advances. According to epidemiological and basic studies …
Melatonin and circadian rhythms in liver diseases: Functional roles and potential therapies
Circadian rhythms and clock gene expressions are regulated by the suprachiasmatic
nucleus in the hypothalamus, and melatonin is produced in the pineal gland. Although the …
nucleus in the hypothalamus, and melatonin is produced in the pineal gland. Although the …
[HTML][HTML] LncRNA CRNDE facilitates epigenetic suppression of CELF2 and LATS2 to promote proliferation, migration and chemoresistance in hepatocellular …
SC Xie, JQ Zhang, XL Jiang, YY Hua, SW Xie… - Cell death & …, 2020 - nature.com
Our study aimed to investigate the expression, functional significance, and related
mechanism of long noncoding RNA CRNDE (colorectal neoplasia differentially expressed) …
mechanism of long noncoding RNA CRNDE (colorectal neoplasia differentially expressed) …
[HTML][HTML] Small molecule-nanobody conjugate induced proximity controls intracellular processes and modulates endogenous unligandable targets
Chemically induced proximity (CIP) is a powerful tool to study cellular functions. However
with current CIP inducers it is difficult to directly modulate unligandable and endogenous …
with current CIP inducers it is difficult to directly modulate unligandable and endogenous …
[HTML][HTML] Emodin sensitizes hepatocellular carcinoma cells to the anti-cancer effect of sorafenib through suppression of cholesterol metabolism
YS Kim, YM Lee, TI Oh, DH Shin, GH Kim… - International journal of …, 2018 - mdpi.com
Reduced therapeutic efficacy of sorafenib, a first-generation multikinase inhibitor, is often
observed during the treatment of advanced hepatocellular carcinoma (HCC). Emodin is an …
observed during the treatment of advanced hepatocellular carcinoma (HCC). Emodin is an …
1, 2, 4-Triazolo [4, 3-c] quinazolines: a bioisosterism-guided approach towards the development of novel PCAF inhibitors with potential anticancer activity
MH El-Shershaby, A Ghiaty, AH Bayoumi… - New Journal of …, 2021 - pubs.rsc.org
Targeting PCAF with small inhibitor molecules has emerged as a potential therapeutic
strategy for the treatment of cancer. Recently, L-45 was identified as a potent …
strategy for the treatment of cancer. Recently, L-45 was identified as a potent …
RIP kinases in liver cell death, inflammation and cancer
V Kondylis, M Pasparakis - Trends in molecular medicine, 2019 - cell.com
Cell death is intrinsically linked to inflammatory liver disease and cancer development.
Recent genetic studies have suggested that receptor-interacting protein kinase (RIPK) 1 is …
Recent genetic studies have suggested that receptor-interacting protein kinase (RIPK) 1 is …
Lactosylated Chitosan Nanoparticles Potentiate the Anticancer Effects of Telmisartan In Vitro and in a N-Nitrosodiethylamine-Induced Mice Model of Hepatocellular …
Hepatocellular carcinoma (HCC) is the leading cause of cancer-related mortality worldwide.
Telmisartan (TLM), a BSC class II drug, has been reported to have antiproliferative activity in …
Telmisartan (TLM), a BSC class II drug, has been reported to have antiproliferative activity in …